Pharmaceutical cocrystals: An overview

International Journal of Pharmaceutics

Volumn 419, Issue 1-2, 2011, Pages 1-11

  Qiao, Ning ^a   Li, Mingzhong ^a   Schlindwein, Walkiria ^a   Malek, Nazneen ^a   Davies, Angela ^a   Trappitt, Gary ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Cocrystal characterisation; Crystal engineering; Grinding cocrystallisation; Pharmaceutical cocrystal; Solution cocrystallisation; Supramolecular synthon

Indexed keywords

2 [4 (4 CHLORO 2 FLUORPHENOXY)PHENYL]PYRIMIDINE 4 CARBOXAMIDE; ACETAZOLAMIDE; ALCOHOL DERIVATIVE; AMIDE; AMINO ACID; CARBOHYDRATE; CARBOXYLIC ACID; EXEMESTANE; GLUTARIC ACID; HEXAMETHYLENEBISACETAMIDE; IBUPROFEN; INDOMETACIN; MEGESTROL ACETATE; NICOTINAMIDE; SACCHARIN; THEOPHYLLINE; UNCLASSIFIED DRUG;

CHEMICAL MODIFICATION; COOLING CRYSTALLISATION; CRYSTAL; CRYSTAL ENGINEERING; CRYSTAL STRUCTURE; CRYSTALLIZATION; CRYSTALLOGRAPHY; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; EVAPORATION COCRYSTALLISATION; HUMIDITY; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; IONIZATION; MELTING POINT; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHARMACEUTICAL COCRYSTAL; PHARMACEUTICAL ENGINEERING; PHYSICAL CHEMISTRY; POWDER X RAY DIFFRACTION; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REACTION CRYSTALLISATION; REVIEW; ROOM TEMPERATURE; SCANNING ELECTRON MICROSCOPY; SCREENING; SINGLE CRYSTAL X RAY DIFFRACTION; SOLID STATE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLVENT DROP GRINDING; SUPRAMOLECULAR CHEMISTRY; SYSTEMATIC REVIEW (TOPIC); TEMPERATURE STRESS; TERAHERTZ SPECTROSCOPY; ULTRASOUND ASSISTED SOLUTION COCRYSTALLISATION; X RAY DIFFRACTION;

EID: 80053574884     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.07.037     Document Type: Short Survey

References (98)

1. C.B. Aakeröy, M. Fasulo, N. Schultheiss, J. Desper, and C. Moore Structural competition between hydrogen bonds and halogen bonds J. Am. Chem. Soc. 129 2007 13772 13773 (Pubitemid 350106044)
2. C.B. Aakeröy, S. Forbes, and J. Desper Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug J. Am. Chem. Soc. 131 2009 17048 17049
3. C.B. Aakeröy, and D.J. Salmon Building co-crystals with molecular sense and supramolecular sensibility CrystEngComm 7 2005 439 448 (Pubitemid 41396867)
4. C.B. Aakeröy, D.J. Salmon, M.M. Smith, and J. Desper Cyanophenyloximes: reliable and versatile tools for hydrogen-bond directed supramolecular synthesis of cocrystals Cryst. Growth Des. 6 2006 1033 1042 (Pubitemid 43672345)
5. S. Aher, R. Dhumal, K. Mahadik, A. Paradkar, and P. York Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: caffeine/maleic acid Eur. J. Pharm. Sci. 41 2010 597 602
6. A. Ainouz, J.-R. Authelin, P. Billot, and H. Lieberman Modeling and prediction of cocrystal phase diagrams Int. J. Pharm. 374 2009 82 89
7. O. Almarsson, and M.J. Zaworotko Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Chem. Commun. 2004 1889 1896 (Pubitemid 39335992)
8. K. Amin, R.-M. Dannenfelser, J. Zielinski, and B. Wang Lyophilization of polyethylene glycol mixtures J. Pharm. Sci. 93 2004 2244 2249 (Pubitemid 39129622)
9. J.I. Arenas-Garcia, D. Herrera-Ruiz, K. Mondragon-Vasquez, H. Morales-Rojas, and H. Hopfl Co-crystals of active pharmaceutical ingredients - acetazolamide Cryst. Growth Des. 10 2010 3732 3742
10. A. Bak, A. Gore, E. Yanez, M. Stanton, S. Tufekcic, R. Syed, A. Akrami, M. Rose, S. Surapaneni, T. Bostick, A. King, S. Neervannan, D. Ostovic, and A. Koparkar The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics J. Pharm. Sci. 97 2008 3942 3956
11. S. Basavoju, D. Boström, and S. Velaga Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization Pharm. Res. 25 2008 530 541 (Pubitemid 351357724)
12. M. Bermejo, and I. Gonzalez-Alvarez How and where are drugs absorbed? S.C. Gad, Preclinical Development Handbook: ADME and Biopharmaceutical Properties 2007 John Wiley & Sons, Inc. Hoboken 249 280
13. D.J. Berry, C.C. Seaton, W. Clegg, R.W. Harrington, S.J. Coles, P.N. Horton, M.B. Hursthouse, R. Storey, W. Jones, T. Friscic, and N. Blagden Applying hot-stage microscopy to co-crystal screening: a study of nicotinamide with seven active pharmaceutical ingredients Cryst. Growth Des. 8 2008 1697 1712
14. S.J. Bethune, N. Huang, A. Jayasankar, and N. Rodriguez-Hornedo Understanding and predicting the effect of cocrystal components and pH on cocrystal solubility Cryst. Growth Des. 9 2009 3976 3988
15. J.A. Bis, P. Vishweshwar, D. Weyna, and M.J. Zaworotko Hierarchy of supramolecular synthons: persistent hydroxyl⋯pyridine hydrogen bonds in cocrystals that contain a cyano acceptor Mol. Pharm. 4 2007 401 416 (Pubitemid 46983956)
16. N. Blagden, D.J. Berry, A. Parkin, H. Javed, A. Ibrahim, P.T. Gavan, L.L. De Matos, and C.C. Seaton Current directions in co-crystal growth New J. Chem. 32 2008 1659 1672
17. N. Blagden, M. de Matas, P.T. Gavan, and P. York Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates Adv. Drug Deliv. Rev. 59 2007 617 630 (Pubitemid 47285407)
18. D. Braga, S.L. Giaffreda, F. Grepioni, A. Pettersen, L. Maini, M. Curzi, and M. Polito Mechanochemical preparation of molecular and supramolecular organometallic materials and coordination networks Dalton Trans. 2006 1249 1263
19. D. Braga, and F. Grepioni Reactions between or within molecular crystals Angew. Chem., Int. Ed. 43 2004 4002 4011 (Pubitemid 39257445)
20. D. Braga, and F. Grepioni Making crystals from crystals: a green route to crystal engineering and polymorphism Chem. Commun. 2005 3635 3645 (Pubitemid 41133134)
21. N. Chieng, M. Hubert, D. Saville, T. Rades, and J. Aaltonen Formation kinetics and stability of carbamazepine-nicotinamide cocrystals prepared by mechanical activation Cryst. Growth Des. 9 2009 2377 2386
22. S.L. Childs, L.J. Chyall, J.T. Dunlap, V.N. Smolenskaya, B.C. Stahly, and G.P. Stahly Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids J. Am. Chem. Soc. 126 2004 13335 13342 (Pubitemid 39382761)
23. S.L. Childs, N. Rodriguez-Hornedo, L.S. Reddy, A. Jayasankar, C. Maheshwari, L. McCausland, R. Shipplett, and B.C. Stahly Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine CrystEngComm 10 2008 856 864
24. E. Cho, W. Cho, K.-H. Cha, J. Park, M.-S. Kim, J.-S. Kim, H.J. Park, and S.-J. Hwang Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives Int. J. Pharm. 396 2010 91 98
25. D. Cinčić, T. Friščić, and W. Jones Isostructural materials achieved by using structurally equivalent donors and acceptors in halogen-bonded cocrystals Chem. Eur. J. 14 2008 747 753
26. S.H. Dale, M.R.J. Elsegood, M. Hemmings, and A.L. Wilkinson The co-crystallisation of pyridine with benzenepolycarboxylic acids: the interplay of strong and weak hydrogen bonding motifs CrystEngComm 6 2004 207 214 (Pubitemid 40464487)
27. G.R. Desiraju Supramolecular synthons in crystal engineering - a new organic synthesis Angew. Chem., Int. Ed. Engl. 34 1995 2311 2327
28. R.S. Dhumal, S.V. Biradar, A.R. Paradkar, and P. York Ultrasound assisted engineering of lactose crystals Pharm. Res. 25 2008 2835 2844
29. R.S. Dhumal, S.V. Biradar, A.R. Paradkar, and P. York Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery Int. J. Pharm. 368 2009 129 137
30. R.S. Dhumal, S.V. Biradar, S. Yamamura, A.R. Paradkar, and P. York Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability Eur. J. Pharm. Biopharm. 70 2008 109 115
31. C.A. Ellis, M.A. Miller, J. Spencer, J. Zukerman-Schpector, and E.R.T. Tiekink Co-crystallization experiments of thiocarbamides with bipyridine-type molecules CrystEngComm 11 2009 1352 1361
32. M.C. Etter Encoding and decoding hydrogen-bond patterns of organic compounds Acc. Chem. Res. 23 1990 120 126
33. M.C. Etter Hydrogen bonds as design elements in organic chemistry J. Phys. Chem. 95 1991 4601 4610
34. M.C. Etter, J.C. MacDonald, and J. Bernstein Graph-set analysis of hydrogen-bond patterns in organic crystals Acta Crystallogr., Sect. B 46 1990 256 262
35. M.C. Etter, and S.M. Reutzel Hydrogen bond directed cocrystallization and molecular recognition properties of acyclic imides J. Am. Chem. Soc. 113 1991 2586 2598
36. S.G. Fleischman, S.S. Kuduva, J.A. McMahon, B. Moulton, R.D. Bailey Walsh, N. Rodríguez-Hornedo, and M.J. Zaworotko Crystal engineering of the composition of pharmaceutical phases: multiple-component crystalline solids involving carbamazepine Cryst. Growth Des. 3 2003 909 919 (Pubitemid 37474229)
37. T. Friščić, and W. Jones Recent advances in understanding the mechanism of cocrystal formation via grinding Cryst. Growth Des. 9 2009 1621 1637
38. T. Friščić, and W. Jones Benefits of cocrystallisation in pharmaceutical materials science: an update J. Pharm. Pharmacol. 62 2010 1547 1559
39. E. Gagniere, D. Mangin, F. Puel, C. Bebon, J.P. Klein, O. Monnier, and E. Garcia Cocrystal formation in solution: in situ solute concentration monitoring of the two components and kinetic pathways Cryst. Growth Des. 9 2009 3376 3383
40. E. Gagniere, D. Mangin, F. Puel, A. Rivoire, O. Monnier, E. Garcia, and J.R. Klein Formation of co-crystals: kinetic and thermodynamic aspects J. Cryst. Growth 311 2009 2689 2695
41. D.J. Good, and N. Rodriguez-Hornedo Cocrystal eutectic constants and prediction of solubility behavior Cryst. Growth Des. 10 2010 1028 1032
42. M. Habgood, M.A. Deij, J. Mazurek, S.L. Price, and J.H. ter Horst Carbamazepine co-crystallization with pyridine carboxamides: rationalization by complementary phase diagrams and crystal energy landscapes Cryst. Growth Des. 10 2009 903 912
43. G. He, P.S. Chow, and R.B.H. Tan Investigating the intermolecular interactions in concentration-dependent solution cocrystallization of caffeine and p-hydroxybenzoic acid Cryst. Growth Des. 10 2010 3763 3769
44. G.W. He, C. Jacob, L.F. Guo, P.S. Chow, and R.B.H. Tan Screening for cocrystallization tendency: the role of intermolecular interactions J. Phys. Chem. B 112 2008 9890 9895
45. M.B. Hickey, M.L. Peterson, L.A. Scoppettuolo, S.L. Morrisette, A. Vetter, H. Guzmán, J.F. Remenar, Z. Zhang, M.D. Tawa, S. Haley, M.J. Zaworotko, and Ö. Almarsson Performance comparison of a co-crystal of carbamazepine with marketed product Eur. J. Pharm. Biopharm. 67 2007 112 119 (Pubitemid 46991320)
46. J.-Y. Hong, J.-K. Kim, Y.-K. Song, J.-S. Park, and C.-K. Kim A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption J. Control. Release 110 2006 332 338 (Pubitemid 41827486)
47. L.F. Huang, and W.Q. Tong Impact of solid state properties on developability assessment of drug candidates Adv. Drug Deliv. Rev. 56 2004 321 334
48. A. Jayasankar, A. Somwangthanaroj, Z.J. Shao, and N. Rodriguez-Hornedo Cocrystal formation during cogrinding and storage is mediated by amorphous phase Pharm. Res. 23 2006 2381 2392 (Pubitemid 44511518)
49. S.L. Johnson, and K.A. Rumon Infrared spectra of solid 1:1 pyridine-benzoic acid complexes; the nature of the hydrogen bond as a function of the acid-base levels in the complex 1 J. Phys. Chem. 69 1965 74 86
50. M.-S. Jung, J.-S. Kim, M.-S. Kim, A. Alhalaweh, W. Cho, S.-J. Hwang, and S.P. Velaga Bioavailability of indomethacin-saccharin cocrystals J. Pharm. Pharmacol. 62 2010 1560 1568
51. N. Kaneniwa, J. Ichikawa, T. Yamaguchi, K. Hayashi, N. Watari, and M. Sumi Dissolution behaviour of carbamazepine polymorphs Yakugaku Zasshi 107 1987 808 813 (Pubitemid 18084858)
52. M. Khan, V. Enkelmann, and G. Brunklaus Crystal engineering of pharmaceutical co-crystals: application of methyl paraben as molecular hook J. Am. Chem. Soc. 132 2010 5254 5263
53. Y. Kobayashi, S. Ito, S. Itai, and K. Yamamoto Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate Int. J. Pharm. 193 2000 137 146 (Pubitemid 30001856)
54. H.-G. Lee, G.G.Z. Zhang, and D.R. Flanagan Cocrystal intrinsic dissolution behavior using a rotating disk J. Pharm. Sci. 100 2010 1736 1744
55. T. Lee, and P.Y. Wang Screening, manufacturing. photoluminescence, and molecular recognition of co-crystals: cytosine with dicarboxylic acids Cryst. Growth Des. 10 2010 1419 1434
56. N. Li, M.D. DeGennar, W. Liebenberg, L.R. Tiedt, A.S. Zahn, M.V. Pishko, and M.M. de Villiers Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process Pharmazie 61 2006 595 603 (Pubitemid 44098026)
57. 15N NMR spectroscopy J. Am. Chem. Soc. 128 2006 8199 8210 (Pubitemid 43967764)
58. E. Lu, N. Rodriguez-Hornedo, and R. Suryanarayanan A rapid thermal method for cocrystal screening CrystEngComm 10 2008 665 668
59. J. Lu, and S. Rohani Preparation and characterization of theophylline-nicotinamide cocrystal Org. Process Res. Dev. 13 2009 1269 1275
60. J.A. McMahon, J.A. Bis, P. Vishweshwar, T.R. Shattock, O.L. McLaughlin, and M.J. Zaworotko Crystal engineering of the composition of pharmaceutical phases. 3. Primary amide supramolecular heterosynthons and their role in the design of pharmaceutical co-crystals Z. Kristallogr. 220 2005 340 350 (Pubitemid 40515882)
61. D.P. McNamara, S.L. Childs, J. Giordano, A. Iarriccio, J. Cassidy, M.S. Shet, R. Mannion, E. O'Donnell, and A. Park Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API Pharm. Res. 23 2006 1888 1897 (Pubitemid 44200553)
62. M.C. Meyer, A.B. Straughn, R.M. Mhatre, V.P. Shah, R.L. Williams, and L.J. Lesko The relative bioavailability and in vivo in vitro correlations for four marketed carbamazepine tablets Pharm. Res. 15 1998 1787 1791 (Pubitemid 28524593)
63. I. Miroshnyk, S. Mirza, and N. Sandler Pharmaceutical co-crystals-an opportunity for drug product enhancement Expert Opin. Drug Deliv. 6 2009 333 341
64. M.A. Mohammad, A. Alhalaweh, and S.P. Velaga Hansen solubility parameter as a tool to predict cocrystal formation Int. J. Pharm. 407 2011 63 71
65. S.A. Myz, T.P. Shakhtshneider, K. Fucke, A.P. Fedotov, E.V. Boldyreva, V.V. Boldyrev, and N.I. Kuleshova Synthesis of co-crystals of meloxicam with carboxylic acids by grinding Mendeleev Commun. 19 2009 272 274
66. L.M. Oberoi, K.S. Alexander, and A.T. Riga Study of interaction between ibuprofen and nicotinamide using differential scanning calorimetry, spectroscopy, and microscopy and formulation of a fast-acting and possibly better ibuprofen suspension for osteoarthritis patients J. Pharm. Sci. 94 2005 93 101 (Pubitemid 40116373)
67. A. Orpen Applications of the Cambridge Structural Database to molecular inorganic chemistry Acta Crystallogr., Sect. B 58 2002 398 406 (Pubitemid 135702676)
68. I.D.H. Oswald, D.R. Allan, P.A. McGregor, W.D.S. Motherwell, S. Parsons, and C.R. Pulham The formation of paracetamol (acetaminophen) adducts with hydrogen-bond acceptors Acta Crystallogr., Sect. B 58 2002 1057 1066 (Pubitemid 135688541)
69. L. Padrela, M.A. Rodrigues, S.P. Velaga, A.C. Fernandes, H.A. Matos, and E.G. de Azevedo Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process J. Supercrit. Fluids 53 2010 156 164
70. L. Padrela, M.A. Rodrigues, S.P. Velaga, H.A. Matos, and E.G. de Azevedo Formation of indomethacin-saccharin cocrystals using supercritical fluid technology Eur. J. Pharm. Sci. 38 2009 9 17
71. E.P.J. Parrott, J.A. Zeitler, T. Friscic, M. Pepper, W. Jones, G.M. Day, and L.F. Gladden Testing the sensitivity of terahertz spectroscopy to changes in molecular and supramolecular structure: a study of structurally similar cocrystal Cryst. Growth Des. 9 2009 1452 1460
72. PhRMA Pharmaceutical Industry Profile 2006 2006 PhRMA Washington, DC
73. W.W. Porter Iii, S.C. Elie, and A.J. Matzger Polymorphism in carbamazepine cocrystals Cryst. Growth Des. 8 2008 14 16
74. T. Ramanathan Mass Spectrometry in Drug Metabolism and Pharmacokinetics 2009 John Wiley & Sons, Inc. Hoboken, NJ 1 4
75. N. Rasenack, H. Hartenhauer, and B.W. Müller Microcrystals for dissolution rate enhancement of poorly water-soluble drugs Int. J. Pharm. 254 2003 137 145 (Pubitemid 36298822)
76. J.F. Remenar, S.L. Morissette, M.L. Peterson, B. Moulton, J.M. MacPhee, H.R. Guzman, and O. Almarsson Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids J. Am. Chem. Soc. 125 2003 8456 8457 (Pubitemid 36858412)
77. S.M. Reutzel-Edens, and A.W. Newman Physical characterization of hygroscopicity in pharmaceutical solids R. Hilfiker, Polymorphism: In the Pharmaceutical Industry 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 235 258
78. B.K. Saha, A. Nangia, and M. Jaskolski Crystal engineering with hydrogen bonds and halogen bonds CrystEngComm 7 2005 355 358 (Pubitemid 41396881)
79. N. Schultheiss, and A. Newman Pharmaceutical cocrystals and their physicochemical properties Cryst. Growth Des. 9 2009 2950 2967
80. B. Sekhon Pharmaceutical co-crystals - a review Ars Pharmaceutica 50 2009 99 117
81. A.T.M. Serajuddin Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs J. Pharm. Sci. 88 1999 1058 1066
82. N. Shan, F. Toda, and W. Jones Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics Chem. Commun. 2002 2372 2373 (Pubitemid 35283628)
83. N. Shan, and M.J. Zaworotko The role of cocrystals in pharmaceutical science Drug Discov. Today 13 2008 440 446
84. L. Shargel, and A.B. Yu Applied Biopharmaceutics & Pharmacokinetics fourth ed. 1999 McGraw-Hill New York
85. K. Shiraki, N. Takata, R. Takano, Y. Hayashi, and K. Terada Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds Pharm. Res. 25 2008 2581 2592
86. M.K. Stanton, and A. Bak Physicochemical properties of pharmaceutical co-crystals: a case study of ten AMG 517 co-crystals Cryst. Growth Des. 8 2008 3856 3862
87. T. Steiner Competition of hydrogen-bond acceptors for the strong carboxyl donor Acta Crystallogr., Sect. B 57 2001 103 106
88. J.H. ter Horst, M.A. Deij, and P.W. Cains Discovering new co-crystals Cryst. Growth Des. 9 2009 1531 1537
89. V. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 2007 1 16 (Pubitemid 44902565)
90. A.V. Trask, W.D.S. Motherwell, and W. Jones Solvent-drop grinding: green polymorph control of cocrystallisation Chem. Commun. 2004 890 891 (Pubitemid 38530287)
91. A.V. Trask, W.D.S. Motherwell, and W. Jones Physical stability enhancement of theophylline via cocrystallization Int. J. Pharm. 320 2006 114 123 (Pubitemid 44128714)
92. Y. Umeda, T. Fukami, T. Furuishi, T. Suzuki, K. Tanjoh, and K. Tomono Characterization of multicomponent crystal formed between indomethacin and lidocaine Drug Dev. Ind. Pharm. 35 2009 843 851
93. N. Variankaval, R. Wenslow, J. Murry, R. Hartman, R. Helmy, E. Kwong, S.-D. Clas, C. Dalton, and I. Santos Preparation and solid-state characterization of nonstoichiometric cocrystals of a phosphodiesterase-IV inhibitor and l-tartaric acid Cryst. Growth Des. 6 2006 690 700 (Pubitemid 43475360)
94. P. Vishweshwar, J.A. McMahon, J.A. Bis, and M.J. Zaworotko Pharmaceutical co-crystals J. Pharm. Sci. 95 2006 499 516
95. R.D.B. Walsh, M.W. Bradner, S. Fleischman, L.A. Morales, B. Moulton, N. Rodriguez-Hornedo, and M.J. Zaworotko Crystal engineering of the composition of pharmaceutical phases Chem. Commun. 2003 186 187 (Pubitemid 36138703)
96. D.R. Weyna, T. Shattock, P. Vishweshwar, and M.J. Zaworotko Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: mechanochemistry vs slow evaporation from solution Cryst. Growth Des. 9 2009 1106 1123
97. X. Yue, Y. Qiao, N. Qiao, S. Guo, J. Xing, L. Deng, J. Xu, and A. Dong Amphiphilic methoxy poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(2- dimethylaminoethyl methacrylate) cationic copolymer nanoparticles as a vector for gene and drug delivery Biomacromolecules 11 2010 2306 2312
98. G.G.Z. Zhang, R.F. Henry, T.B. Borchardt, and X. Lou Efficient co-crystal screening using solution-mediated phase transformation J. Pharm. Sci. 96 2007 990 995 (Pubitemid 46797470)